Page last updated: 2024-10-20

taurine and Neoplasms

taurine has been researched along with Neoplasms in 44 studies

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
"Based on evaluated non-clinical studies, taurine ameliorates chemotherapy-induced cardiotoxicity, but its possible interaction with the efficacy of anti-cancer medicines that mostly act through induction of oxidants remains to be elucidated in the future."9.12The role of taurine on chemotherapy-induced cardiotoxicity: A systematic review of non-clinical study. ( Abdollahi, M; Armandeh, M; Bameri, B; Eghbal, MA; Haghi-Aminjan, H; Hooshangi Shayesteh, MR; Naddafi, M; Samadi, M; Sattari, M, 2021)
"To determine if the catheter lock taurolidine can reduce the number of catheter-related bloodstream infections (CRBSI) in pediatric cancer patients with tunneled central venous catheters (CVC)."5.17Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. ( Handrup, MM; Møller, JK; Schrøder, H, 2013)
"Based on evaluated non-clinical studies, taurine ameliorates chemotherapy-induced cardiotoxicity, but its possible interaction with the efficacy of anti-cancer medicines that mostly act through induction of oxidants remains to be elucidated in the future."5.12The role of taurine on chemotherapy-induced cardiotoxicity: A systematic review of non-clinical study. ( Abdollahi, M; Armandeh, M; Bameri, B; Eghbal, MA; Haghi-Aminjan, H; Hooshangi Shayesteh, MR; Naddafi, M; Samadi, M; Sattari, M, 2021)
"Taurolidine is an antimicrobial agent that was originally used in the local treatment of peritonitis and was shown to be effective in the prevention of catheter-related bloodstream infections (CR-BSI)."2.71Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients. ( Koldehoff, M; Zakrzewski, JL, 2004)
"Taurolidine has been used as an antimicrobial agent in the clinical setting since the 1970s and thus far appears nontoxic."2.46The evolving role of taurolidine in cancer therapy. ( Bouchier-Hayes, DJ; Hallihan, P; Neary, PM; Pfirrmann, RW; Redmond, HP; Wang, JH, 2010)
"Nonetheless, cancer cells continuously proliferate under such high-stressed conditions through incompletely understood mechanisms."1.91TUG1-mediated R-loop resolution at microsatellite loci as a prerequisite for cancer cell proliferation. ( Iijima, K; Kataoka, K; Kibe, Y; Kitano, Y; Kobayashi, J; Kondo, Y; Mamiya, A; Miyata, K; Murofushi, Y; Nishimura, T; Ogami, K; Ohka, F; Saito, R; Sato, S; Shinjo, K; Suzuki, HI; Suzuki, MM; Wang, X; Xie, J; Yao, R, 2023)
"Taurolidine lock was also safe and effective in treating device colonization."1.91Taurolidine lock in the treatment of colonization and infection of totally implanted venous access devices in cancer patients. ( Bottos, P; Brescia, F; Da Ros, V; Fabiani, F; Moreal, C; Nadalini, E; Pittiruti, M; Scoppettuolo, G; Zanier, C, 2023)
"CD44 knockdown in cancer diminished glutathione, but not HT in tumours."1.48Gold-nanofève surface-enhanced Raman spectroscopy visualizes hypotaurine as a robust anti-oxidant consumed in cancer survival. ( Hiraoka, N; Hishiki, T; Itoh, M; Kabe, Y; Koike, D; Kubo, A; Morikawa, T; Nagano, O; Nagashima, H; Naya, M; Ohmura, M; Sampetrean, O; Saya, H; Shiota, M; Suematsu, M; Sugiura, Y; Suina, K; Takahashi, H; Takubo, K; Tani, T; Watanabe, H; Yamamoto, T; Yamazoe, S, 2018)
"The anticancer-drug cyclophosphamide (CP) is known to have nephrotoxicity."1.46Potential urinary biomarkers of nephrotoxicity in cyclophosphamide-treated rats investigated by NMR-based metabolic profiling. ( Choi, HK; Hyun, SH; Kim, DH; Kim, JY; Kim, SH; Lee, SG; Lim, SR; Moon, KS; Park, SJ; Sul, D, 2017)
"has safe & effective anticancer effects, while commonly used 2000-5000 I."1.43Optimal Dose of Vitamin D3 400 I.U. for Average Adults has A Significant Anti-Cancer Effect, While Widely Used 2000 I.U. or Higher Promotes Cancer: Marked Reduction of Taurine & 1α, 25(OH)2D3 Was Found In Various Cancer Tissues and Oral Intake of Optimal ( Duvvi, H; Jones, MK; Lu, D; Nihrane, A; Ohki, M; Omura, Y; Shimotsuura, Y; Yapor, D, 2016)
"In bladder, renal, and prostate cancer, the reason for the insufficient (."1.35Apoptosis-inducing high (.)NO concentrations are not sustained either in nascent or in developed cancers. ( Heller, A, 2008)
"Treatment with taurine prior to stimulation down-regulated FasL protein expression and partially inhibited apoptosis."1.33Taurine attenuates CD3/interleukin-2-induced T cell apoptosis in an in vitro model of activation-induced cell death (AICD). ( Bouchier-Hayes, DJ; Condron, CE; Maher, SG; Toomey, DM, 2005)
"The pharmacokinetic properties of tauromustine (TCNU) were studied in 31 cancer patients who participated in phase I trials."1.28Pharmacokinetics of tauromustine in cancer patients. Phase I studies. ( Ellman, M; Gunnarsson, PO; Hansen, HH; Macpherson, JS; Polacek, J; Smyth, JF; Vibe-Petersen, J; Warrington, PS, 1989)
"Eighty-four patients with refractory cancer received 12 dose escalations from 10-150 mg/m2 TCNU administered orally every 6 weeks."1.27Phase I study of TCNU, a novel nitrosourea. ( Cornbleet, MA; Kerr, ME; Leonard, RC; Macpherson, JS; Smyth, JF; Warrington, PS; Whelan, JM, 1987)

Research

Studies (44)

TimeframeStudies, this research(%)All Research%
pre-199013 (29.55)18.7374
1990's1 (2.27)18.2507
2000's13 (29.55)29.6817
2010's10 (22.73)24.3611
2020's7 (15.91)2.80

Authors

AuthorsStudies
Diamandis, P1
Wildenhain, J1
Clarke, ID1
Sacher, AG1
Graham, J1
Bellows, DS1
Ling, EK1
Ward, RJ1
Jamieson, LG1
Tyers, M1
Dirks, PB1
Doss, HM1
Kim, JY2
Kim, KS1
Stary, D1
Bajda, M1
Suzuki, MM1
Iijima, K1
Ogami, K1
Shinjo, K1
Murofushi, Y1
Xie, J1
Wang, X1
Kitano, Y1
Mamiya, A1
Kibe, Y1
Nishimura, T1
Ohka, F1
Saito, R1
Sato, S1
Kobayashi, J1
Yao, R1
Miyata, K1
Kataoka, K1
Suzuki, HI1
Kondo, Y1
Baliou, S1
Kyriakopoulos, AM1
Spandidos, DA1
Zoumpourlis, V1
Dotsenko, O1
Shtofel, D1
Samadi, M1
Haghi-Aminjan, H1
Sattari, M1
Hooshangi Shayesteh, MR1
Bameri, B1
Armandeh, M1
Naddafi, M1
Eghbal, MA1
Abdollahi, M1
Brescia, F1
Pittiruti, M1
Scoppettuolo, G1
Zanier, C1
Nadalini, E1
Bottos, P1
Moreal, C1
Da Ros, V1
Fabiani, F1
Longo, R1
Llorens, M1
Goetz, C1
Platini, C1
Eid, N1
Sellies, J1
Ouamara, N1
Quétin, P1
Fragai, M1
Comito, G1
Di Cesare Mannelli, L1
Gualdani, R1
Calderone, V1
Louka, A1
Richichi, B1
Francesconi, O1
Angeli, A1
Nocentini, A1
Gratteri, P1
Chiarugi, P1
Ghelardini, C1
Tadini-Buoninsegni, F1
Supuran, CT1
Nativi, C1
Shiota, M1
Naya, M1
Yamamoto, T1
Hishiki, T1
Tani, T1
Takahashi, H1
Kubo, A1
Koike, D1
Itoh, M1
Ohmura, M1
Kabe, Y1
Sugiura, Y1
Hiraoka, N1
Morikawa, T1
Takubo, K1
Suina, K1
Nagashima, H1
Sampetrean, O1
Nagano, O1
Saya, H1
Yamazoe, S1
Watanabe, H1
Suematsu, M1
Handrup, MM1
Møller, JK1
Schrøder, H1
Möhler, H1
Pfirrmann, RW2
Frei, K1
Omura, Y1
Lu, D1
Jones, MK1
Nihrane, A1
Duvvi, H1
Yapor, D1
Shimotsuura, Y1
Ohki, M1
Lim, SR1
Hyun, SH1
Lee, SG1
Kim, SH1
Park, SJ1
Moon, KS1
Sul, D1
Kim, DH1
Choi, HK1
Pavlov, VA1
Kotomtsev, VV1
Doronin, AI1
Sabadash, EV1
Simon, A1
Ammann, RA1
Wiszniewsky, G1
Bode, U1
Fleischhack, G1
Besuden, MM1
Heller, A1
Sadzuka, Y1
Matsuura, M1
Sonobe, T1
Neary, PM1
Hallihan, P1
Wang, JH1
Bouchier-Hayes, DJ2
Redmond, HP1
Chromik, AM1
Daigeler, A1
Bulut, D1
Flier, A1
May, C1
Harati, K1
Roschinsky, J1
Sülberg, D1
Ritter, PR1
Mittelkötter, U1
Hahn, SA1
Uhl, W1
Ozgen, U1
Türköz, Y1
Stout, M1
Ozuğurlu, F1
Pelik, F1
Bulut, Y1
Aslan, M1
Ravindranath, Y1
Savaşan, S1
GREEN, JP1
DAY, M1
ROBINSON, JD1
SONGSTER, CL1
SCHOCHET, SS1
FARBER, E1
TURNER, FP1
BRUM, VC1
PAQUETTE, WW1
WELDEN, RB1
Koldehoff, M1
Zakrzewski, JL1
Maher, SG1
Condron, CE1
Toomey, DM1
Tome, ME1
Briehl, MM1
Lutz, NW1
Jacobi, CA2
Menenakos, C1
Braumann, C2
Kim, C1
Gupta, RC1
Rosado, JO1
Salvador, M1
Bonatto, D1
Tangermann, J1
Müller, JM1
Dubiel, W1
Láng, I1
Feuer, L1
Nékám, K1
Perl, A1
Szigeti, A1
Gergely, P1
Fehér, J1
Lin, JK1
Liaw, KY1
Kamada, S1
Maeda, M1
Tsuji, A1
Baldetorp, L1
Mårtensson, J1
Hack, V1
Schmid, D1
Breitkreutz, R1
Stahl-Henning, C1
Drings, P1
Kinscherf, R1
Taut, F1
Holm, E1
Dröge, W1
Gunnarsson, PO1
Vibe-Petersen, J2
Macpherson, JS2
Warrington, PS2
Polacek, J1
Ellman, M1
Hansen, HH2
Smyth, JF2
Workman, P1
Bork, E1
Møller, H1
Kerr, ME1
Whelan, JM1
Cornbleet, MA1
Leonard, RC1
Moroni, F1
Guidotti, A1
Mugelli, A1
Mannaioni, PF1
Nishida, H1
Tanabe, M1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomised Study of Taurolock for the Locking of Tunneled Central Venous Catheters in Children With Malignant Diseases.[NCT00735813]Phase 3129 participants (Actual)Interventional2008-04-30Completed
Prospective, Randomized, Controlled Trial Evaluating the Efficacy of a Lock-therapy With a Solution of Taurolidine/Citrate (TauroLock) vs Standard Saline Solution for the Primary Prevention of Catheter-related Infections (CLI) in Adult Patients Wtih a Non[NCT02279121]162 participants (Actual)Interventional2014-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

10 reviews available for taurine and Neoplasms

ArticleYear
Taurine and Creatine Transporters as Potential Drug Targets in Cancer Therapy.
    International journal of molecular sciences, 2023, Feb-14, Volume: 24, Issue:4

    Topics: Creatine; Ligands; Membrane Transport Proteins; Neoplasms; Taurine

2023
Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).
    International journal of oncology, 2020, Volume: 57, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cell Proliferation; Disease Models, Animal

2020
The role of taurine on chemotherapy-induced cardiotoxicity: A systematic review of non-clinical study.
    Life sciences, 2021, Jan-15, Volume: 265

    Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Cardiotoxicity; H

2021
Redox-directed cancer therapeutics: Taurolidine and Piperlongumine as broadly effective antineoplastic agents (review).
    International journal of oncology, 2014, Volume: 45, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Cell Survival; Dioxolanes; Humans; Neoplasms; Oxidation-Reduction;

2014
The evolving role of taurolidine in cancer therapy.
    Annals of surgical oncology, 2010, Volume: 17, Issue:4

    Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Taurine; Thiadiazines

2010
Taurolidine--a new drug with anti-tumor and anti-angiogenic effects.
    Anti-cancer drugs, 2005, Volume: 16, Issue:9

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Prolifera

2005
Taurine analogues and taurine transport: therapeutic advantages.
    Advances in experimental medicine and biology, 2006, Volume: 583

    Topics: Aging; Animals; Antioxidants; Behavior; Bile Acids and Salts; Body Temperature; Bone and Bones; Card

2006
Importance of the trans-sulfuration pathway in cancer prevention and promotion.
    Molecular and cellular biochemistry, 2007, Volume: 301, Issue:1-2

    Topics: Adenosylhomocysteinase; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Glutathione; Humans;

2007
Novel anti-angiogenic compounds for application in tumor therapy - COP9 signalosome-associated kinases as possible targets.
    Mini reviews in medicinal chemistry, 2008, Volume: 8, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; COP9 Signalosome Complex; Curcumin; Drug Sc

2008
TCNU: a ray of hope for designer nitrosoureas?
    European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:12

    Topics: Antineoplastic Agents; Humans; Neoplasms; Nitrosourea Compounds; Taurine

1987

Trials

3 trials available for taurine and Neoplasms

ArticleYear
Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC).
    Oncology, 2017, Volume: 93, Issue:2

    Topics: Aged; Anti-Infective Agents; Biofilms; Catheter-Related Infections; Catheters, Indwelling; Central V

2017
Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin.
    Pediatric blood & cancer, 2013, Volume: 60, Issue:8

    Topics: Adolescent; Adult; Anti-Infective Agents; Anticoagulants; Central Venous Catheters; Child; Child, Pr

2013
Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients.
    International journal of antimicrobial agents, 2004, Volume: 24, Issue:5

    Topics: Adult; Anti-Infective Agents; Bacteremia; Catheterization, Central Venous; Female; Humans; Male; Neo

2004

Other Studies

31 other studies available for taurine and Neoplasms

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic

2007
Taurine Supplementation Inhibits the Expression of Atrogin-1 and MURF-1, Protein Degradation Marker Genes, in Skeletal Muscle of C26-Induced Cachexia Mouse Model.
    Advances in experimental medicine and biology, 2022, Volume: 1370

    Topics: Animals; Cachexia; Dietary Supplements; Disease Models, Animal; Mice; Muscle, Skeletal; Muscular Atr

2022
TUG1-mediated R-loop resolution at microsatellite loci as a prerequisite for cancer cell proliferation.
    Nature communications, 2023, 08-22, Volume: 14, Issue:1

    Topics: Cell Proliferation; DNA Replication; Humans; Microsatellite Repeats; Neoplasms; R-Loop Structures; T

2023
In Silico Prediction of Metabolic Fluxes in Cancer Cells with Altered S-adenosylmethionine Decarboxylase Activity.
    Cell biochemistry and biophysics, 2021, Volume: 79, Issue:1

    Topics: Adenosine Triphosphate; Adenosylmethionine Decarboxylase; Antineoplastic Agents; Computer Simulation

2021
Taurolidine lock in the treatment of colonization and infection of totally implanted venous access devices in cancer patients.
    The journal of vascular access, 2023, Volume: 24, Issue:1

    Topics: Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Humans; Neop

2023
Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX).
    Journal of medicinal chemistry, 2017, 11-09, Volume: 60, Issue:21

    Topics: Antineoplastic Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cell Line, Tumor; Drug

2017
Gold-nanofève surface-enhanced Raman spectroscopy visualizes hypotaurine as a robust anti-oxidant consumed in cancer survival.
    Nature communications, 2018, 04-19, Volume: 9, Issue:1

    Topics: Animals; Antioxidants; Female; Glutathione; Gold; Humans; Liver; Male; Metal Nanoparticles; Mice; Mi

2018
Optimal Dose of Vitamin D3 400 I.U. for Average Adults has A Significant Anti-Cancer Effect, While Widely Used 2000 I.U. or Higher Promotes Cancer: Marked Reduction of Taurine & 1α, 25(OH)2D3 Was Found In Various Cancer Tissues and Oral Intake of Optimal
    Acupuncture & electro-therapeutics research, 2016, Volume: 41, Issue:1

    Topics: Adult; Cholecalciferol; Dietary Supplements; Dose-Response Relationship, Drug; Female; Humans; Male;

2016
Potential urinary biomarkers of nephrotoxicity in cyclophosphamide-treated rats investigated by NMR-based metabolic profiling.
    Journal of biochemical and molecular toxicology, 2017, Volume: 31, Issue:3

    Topics: Animals; Biomarkers; Cyclophosphamide; Humans; Isoleucine; Kidney; Leucine; Magnetic Resonance Spect

2017
Antioxidant and Antimutagenic Metabolites in Animals with Opposite Sensitivity to Tuberculosis Mycobacteria and Mutagenic Xenobiotics.
    Bulletin of experimental biology and medicine, 2016, Volume: 162, Issue:1

    Topics: Animals; Disease Susceptibility; Ethanolamine; Ethanolamines; Glutathione; Guinea Pigs; Liver; Methi

2016
Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients.
    BMC infectious diseases, 2008, Jul-29, Volume: 8

    Topics: Adolescent; Adult; Anti-Infective Agents; Catheterization, Central Venous; Child; Child, Preschool;

2008
Apoptosis-inducing high (.)NO concentrations are not sustained either in nascent or in developed cancers.
    ChemMedChem, 2008, Volume: 3, Issue:10

    Topics: Apoptosis; Arginase; Erythrocytes; Humans; Neoplasms; Neutrophils; Nitric Oxide; Nitric Oxide Syntha

2008
The effect of taurine, a novel biochemical modulator, on the antitumor activity of doxorubicin.
    Biological & pharmaceutical bulletin, 2009, Volume: 32, Issue:9

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Doxorubicin; Drug Synergism; Humans; Male; Membran

2009
Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines.
    Journal of experimental & clinical cancer research : CR, 2010, Mar-07, Volume: 29

    Topics: Acetylcysteine; Antineoplastic Agents; Caspases; Cell Death; Cell Line, Tumor; Cell Survival; Dose-R

2010
Degradation of vincristine by myeloperoxidase and hypochlorous acid in children with acute lymphoblastic leukemia.
    Leukemia research, 2003, Volume: 27, Issue:12

    Topics: Acetaminophen; Acute Disease; Analgesics, Non-Narcotic; Antineoplastic Agents, Phytogenic; Case-Cont

2003
Some acidic substances in neoplastic mast cells and in the pineal body.
    Biochemical pharmacology, 1962, Volume: 11

    Topics: Cerebrosides; Histamine; Mast Cells; Neoplasms; Neoplasms, Experimental; Neuraminic Acids; Pineal Gl

1962
METABOLISM OF BILE COMPONENTS DURING HEPATOCARCINOGENESIS. I. CONJUGATION OF CHOLIC ACID IN VITRO IN EXPERIMENTAL LIVER CARCINOGENESIS.
    Cancer research, 1963, Volume: 23

    Topics: Bile; Bile Acids and Salts; Carcinogenesis; Cholic Acid; Ethionine; Fluorenes; In Vitro Techniques;

1963
THE URINARY EXCRETION OF FREE TAURINE IN ACUTE AND CHRONIC DISEASE, FOLLOWING SURGICAL TRAUMA, AND IN PATIENTS WITH ACUTE ALCOHOLISM.
    The Journal of surgical research, 1964, Volume: 4

    Topics: Adrenal Cortex Hormones; Alcoholism; Biliary Tract; Biomedical Research; Cholecystitis; Cholelithias

1964
Taurine attenuates CD3/interleukin-2-induced T cell apoptosis in an in vitro model of activation-induced cell death (AICD).
    Clinical and experimental immunology, 2005, Volume: 139, Issue:2

    Topics: Analysis of Variance; Antibodies, Monoclonal; Apoptosis; CD3 Complex; Fas Ligand Protein; Flow Cytom

2005
Increasing the antioxidant defense in WEHI7.2 cells results in a more tumor-like metabolic profile.
    International journal of molecular medicine, 2005, Volume: 15, Issue:3

    Topics: Adenosine Triphosphate; Amino Acids; Animals; Antioxidants; Aspartic Acid; Cell Line, Tumor; Glycoly

2005
Accumulation of taurine in tumor and inflammatory lesions.
    Advances in experimental medicine and biology, 2006, Volume: 583

    Topics: Animals; Cell Line; Inflammation; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; N

2006
[Effect of Litoralon therapy on the lymphocytotoxicity in patients with malignant tumors].
    Orvosi hetilap, 1984, Sep-02, Volume: 125, Issue:36

    Topics: Antibody-Dependent Cell Cytotoxicity; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Gl

1984
Rapid qualitative and quantitative determinations of urinary amino acids by thin layer and high performance liquid chromatography with dabsyl chloride.
    Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association, 1982, Volume: 81, Issue:7

    Topics: Adult; Amino Acids; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Female; Humans

1982
Fluorescence high-performance liquid chromatographic determination of free and conjugated bile acids in serum and bile using 1-bromoacetylpyrene as a pre-labeling reagent.
    Journal of chromatography, 1983, Jan-14, Volume: 272, Issue:1

    Topics: Bile; Bile Acids and Salts; Chromatography, High Pressure Liquid; Fluorescent Dyes; Glycine; Humans;

1983
Urinary excretion of inorganic sulfate, ester sulfate, total sulfur and taurine in cancer patients.
    Acta medica Scandinavica, 1980, Volume: 208, Issue:4

    Topics: Aged; Creatinine; Female; Humans; Male; Middle Aged; Neoplasms; Sulfates; Sulfur; Sulfuric Acid Este

1980
Cystine levels, cystine flux, and protein catabolism in cancer cachexia, HIV/SIV infection, and senescence.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 1997, Volume: 11, Issue:1

    Topics: Adipose Tissue; Adolescent; Adult; Aging; Animals; Cachexia; CD4 Lymphocyte Count; Citrulline; Cysti

1997
Pharmacokinetics of tauromustine in cancer patients. Phase I studies.
    Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:3

    Topics: Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Neoplasms; Nitroso

1989
A phase I clinical evaluation of 1-(2-chloroethyl)-3-[2-(dimethylaminosulphonyl)ethyl]-1-nitrosou rea (TCNU).
    European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Evaluation; H

1987
Phase I study of TCNU, a novel nitrosourea.
    European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Evaluation; F

1987
Effects of some amino acids on the content and uptake of histamine by neoplastic mast cells in vitro.
    Pharmacological research communications, 1974, Volume: 6, Issue:1

    Topics: Amino Acids; Aminobutyrates; Animals; Carboxylic Acids; Clone Cells; Culture Media; Glutamates; Hist

1974
[Clinical experience with taurine in radiotherapy].
    Rinsho hoshasen. Clinical radiography, 1970, Volume: 15, Issue:9

    Topics: Adult; Aged; Child; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Radiotherapy; Taurine

1970